Episode Details
Back to Episodes
Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 1
Season 26
Episode 333
Published 4 days, 14 hours ago
Description
Featuring perspectives from Dr Rachel N Grisham, including the following topics:
- Mechanism, clinical evidence and practical use of avutometinib with defactinib for recurrent low-grade serous ovarian cancer (LGSOC) (0:00)
- A Phase III trial of letrozole alone as front-line treatment for LGSOC (11:11)
- Current and future role of avutometinib with defactinib for LGSOC (19:23)
- A Phase II/III trial of trametinib for recurrent LGSOC: Biomarker analyses and clinical implications (21:37)